Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21732467 | 0.92 | ALOX15 (0.35) | ALOX15ALDH1A1CYP3A4TSHRTDP1 | |
| SCHEMBL21732692 | 0.92 | ALOX15 (0.35) | ALOX15ALDH1A1CYP3A4TSHRTDP1 | |
| SCHEMBL21732719 | 0.87 | ALOX15 (0.32) | ALOX15ALDH1A1CYP3A4TSHRTDP1 | |
| SCHEMBL21732699 | 0.84 | ALOX15 (0.31) | ALOX15ALDH1A1CYP3A4TSHRTDP1 | |
| SCHEMBL28699754 | 0.83 | ALDH1A1 (0.40) | ALOX15ALDH1A1CYP3A4TSHRTDP1 | |
| SCHEMBL25670400 | 0.83 | ALOX15 (0.32) | ALOX15 | |
| SCHEMBL21732709 | 0.83 | ALOX15 (0.34) | ALOX15ALDH1A1CYP3A4TSHRTDP1 | |
| SCHEMBL21732707 | 0.80 | ALOX15 (0.32) | ALOX15ALDH1A1CYP3A4TSHRTDP1 | |
| SCHEMBL21732898 | 0.79 | TSHR (0.34) | ALDH1A1TSHR | |
| SCHEMBL21732712 | 0.79 | TSHR (0.34) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11667866-B2 | Phosphorous containing compounds and uses thereof | AFTON CHEMICAL CORPORATION (US) | 2023-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667866-B2 | Phosphorous containing compounds and uses thereof | SOST, PHOSPHO1, PSPH | ALOX15 735/4885ALDH1A1 4608/4885CYP3A4 4745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.